fbpx
March 16, 2023

Diabetes Drug Promising for Idiopathic Intracranial Hypertension Diabetes Drug Promising for Idiopathic Intracranial Hypertension

Exenatide, a glucagon-like peptide-1 (GLP-1) receptor agonist used to treat type 2 diabetes, may be a potential treatment for idiopathic intracranial hypertension (IIH). In a small […]
March 14, 2023

FDA Approves Zavegepant Nasal Spray for Acute Migraine FDA Approves Zavegepant Nasal Spray for Acute Migraine

The US Food and Drug Administration (FDA) has approved zavegepant (Zavzpret, Pfizer), the first calcitonin gene-related peptide (CGRP) receptor antagonist nasal spray for the acute treatment […]
March 14, 2023

FDA OKs First Drug for Rett Syndrome FDA OKs First Drug for Rett Syndrome

The US Food and Drug Administration (FDA) has approved trofinetide oral solution (Daybue, Acadia Pharmaceuticals) as the first treatment of Rett syndrome in adults and children […]
March 10, 2023

Concussion Symptoms Tied to Long-Term Cognitive Problems Concussion Symptoms Tied to Long-Term Cognitive Problems

Former National Football League players who had symptoms of concussion during their careers showed poorer performance on cognitive testing, compared with nonplayers, new research shows. “Our […]
March 9, 2023

Two Diets Tied to Lower Alzheimer’s Pathology at Autopsy Two Diets Tied to Lower Alzheimer’s Pathology at Autopsy

A novel study provides strong evidence supporting the adoption of a healthy diet to protect the aging brain. In a cohort of deceased older adults, those […]
March 8, 2023

Depressive Symptoms Tied to Higher Stroke Risk, Worse Outcomes Depressive Symptoms Tied to Higher Stroke Risk, Worse Outcomes

Individuals with a history of depressive symptoms have a 46% higher risk for stroke than those with no depression history, new research suggests. Data from the […]
March 7, 2023

Even Mild COVID Is Hard on the Brain Even Mild COVID Is Hard on the Brain

Editor’s note: Find the latest long COVID news and guidance in Medscape’s Long COVID Resource Center. Even mild cases of COVID-19 can affect the function and structure […]
March 3, 2023

New Digital Tools Promising in MS New Digital Tools Promising in MS

SAN DIEGO — A new wearable device detects, with a high degree of precision, various types of visual dysfunction which eventually affects most patients with multiple […]
March 3, 2023

Digital Tool a Better Disability Measure in MS? Digital Tool a Better Disability Measure in MS?

A digital tool to measure walking has the potential to improve measurement of disability among patients with multiple sclerosis (MS). Dr Mark Gudesblatt “When you measure […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0